Scpharmaceuticals Correlations

SCPH Stock

USD 3.28 0.14 4.09%

The current 90-days correlation between Scpharmaceuticals and Milestone Pharmaceuticals is 0.23 (i.e., Modest diversification). The correlation of Scpharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Scpharmaceuticals Correlation With Market

Significant diversification

The correlation between Scpharmaceuticals and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scpharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.

Moving together with Scpharmaceuticals Stock

0.8	EQ	Equillium	Pair Corr
0.87	ME	23Andme Holding	Pair Corr
0.9	VALN	Valneva SE ADR	Pair Corr
0.72	DNLI	Denali Therapeutics	Pair Corr
0.82	DNTH	Dianthus Therapeutics	Pair Corr
0.9	DRRX	Durect	Pair Corr
0.82	DTIL	Precision BioSciences	Pair Corr
0.84	VIGL	Vigil Neuroscience	Pair Corr
0.87	VINC	Vincerx Pharma	Pair Corr
0.85	VKTX	Viking Therapeutics	Pair Corr
0.75	VRCA	Verrica Pharmaceuticals	Pair Corr
0.86	VRDN	Viridian Therapeutics Buyout Trend	Pair Corr
0.74	VRPX	Virpax Pharmaceuticals	Pair Corr
0.61	VRTX	Vertex Pharmaceuticals	Pair Corr
0.68	VTGN	VistaGen Therapeutics	Pair Corr

Moving against Scpharmaceuticals Stock

0.85	VCEL	Vericel Corp Ord	Pair Corr
0.79	VCYT	Veracyte Potential Growth	Pair Corr
0.76	DYAI	Dyadic International	Pair Corr
0.68	DRTS	Alpha Tau Medical	Pair Corr
0.66	DVAX	Dynavax Technologies	Pair Corr
0.61	DMAC	DiaMedica Therapeutics	Pair Corr
0.59	CDIOW	Cardio Diagnostics	Pair Corr
0.56	SRZNW	Surrozen Warrant	Pair Corr
0.55	KTTAW	Pasithea Therapeutics	Pair Corr
0.45	SABSW	SAB Biotherapeutics	Pair Corr
0.63	VRNA	Verona Pharma PLC	Pair Corr
0.57	ELTX	Elicio Therapeutics	Pair Corr
0.55	VSTM	Verastem	Pair Corr
0.48	VTRS	Viatris	Pair Corr
0.41	ELUT	Elutia Inc	Pair Corr
0.4	ENTX	Entera Bio	Pair Corr
0.39	VTVT	vTv Therapeutics	Pair Corr
0.35	ELDN	Eledon Pharmaceuticals	Pair Corr
0.31	ELEV	Elevation Oncology	Pair Corr

Related Correlations Analysis

	MIST	ONCY	MCRB	LIFE	DMAC	LYRA	CNTA	SCPS	MNPR
MIST		-0.71	0.25	-0.2	0.64	-0.42	0.4	0.31	0.61	MIST
ONCY	-0.71		-0.33	0.3	-0.73	0.73	-0.39	-0.16	-0.82	ONCY
MCRB	0.25	-0.33		0.05	0.66	-0.25	0.3	0.13	0.22	MCRB
LIFE	-0.2	0.3	0.05		-0.27	0.24	0.05	0.07	-0.22	LIFE
DMAC	0.64	-0.73	0.66	-0.27		-0.47	0.32	0.23	0.64	DMAC
LYRA	-0.42	0.73	-0.25	0.24	-0.47		-0.43	-0.1	-0.56	LYRA
CNTA	0.4	-0.39	0.3	0.05	0.32	-0.43		0.12	0.24	CNTA
SCPS	0.31	-0.16	0.13	0.07	0.23	-0.1	0.12		0.16	SCPS
MNPR	0.61	-0.82	0.22	-0.22	0.64	-0.56	0.24	0.16		MNPR
	MIST	ONCY	MCRB	LIFE	DMAC	LYRA	CNTA	SCPS	MNPR

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LYRA	+ 0.73	ONCY
DMAC	+ 0.66	MCRB
DMAC	+ 0.64	MIST
MNPR	+ 0.64	DMAC
MNPR	+ 0.61	MIST
CNTA	+ 0.4	MIST

High negative correlations

MNPR	- 0.82	ONCY
DMAC	- 0.73	ONCY
ONCY	- 0.71	MIST
MNPR	- 0.56	LYRA
LYRA	- 0.47	DMAC
CNTA	- 0.43	LYRA

Risk-Adjusted Indicators

There is a big difference between Scpharmaceuticals Stock performing well and Scpharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Scpharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
MIST	2.49	0.48	0.14	0.56	2.96	(3.00)	7.43	(6.08)	20.63
ONCY	3.23	(0.50)	0.00	(0.46)	0.00	0.00	6.59	(6.67)	27.01
MCRB	4.19	(0.01)	0.00	0.01	4.26	(6.04)	10.00	(6.78)	28.84
LIFE	2.57	0.40	0.13	2.62	2.62	(3.23)	6.45	(5.29)	28.98
DMAC	3.40	0.50	0.12	1.06	3.79	(4.01)	8.64	(5.65)	47.69
LYRA	4.26	(0.01)	0.00	(0.02)	6.06	(6.71)	10.53	(10.00)	40.57
CNTA	2.71	(0.10)	0.00	(0.57)	0.00	0.00	6.30	(6.19)	15.71
SCPS	11.28	0.25	0.01	(0.10)	12.41	(15.59)	33.33	(23.33)	56.67
MNPR	18.80	9.44	0.77	(0.88)	8.07	(22.25)	14.91	(11.81)	653.56

Scpharmaceuticals Corporate Management

John PharmD	Senior Affairs	Profile
Rachael Nokes	Principal Accounting Officer	Profile
Katherine Taudvin	Director Relations	Profile
Michael Hassman	Senior Operations	Profile
Steve Parsons	Senior Commercial	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC